Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

6.7K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
6.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Determinants of poor speech discrimination in a primary care otolaryngology population: a retrospective observational study.

BMC primary care·2026
Same author

Machine learning-based integration of transcriptome and digital pathology for predicting chemoresistance in muscle-invasive bladder cancer.

Experimental & molecular medicine·2026
Same author

Combined impact of ROR2 and its ligands on the pathogenesis and prognosis of idiopathic pulmonary fibrosis.

Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG·2026
Same author

Erratum: [Corrigendum] Role of EphA2-PI3K signaling in vasculogenic mimicry induced by cancer-associated fibroblasts in gastric cancer cells.

Oncology letters·2026
Same author

Uncovering the acetylation sites of Dnmt3L that regulate protein stability and differentiation potency in embryonic stem cells.

Experimental & molecular medicine·2026
Same author

Application of adipose-derived mesenchymal stem cell 3D structure, Microblock, as a skin regeneration therapy.

European journal of pharmacology·2026

Related Experiment Video

Updated: Jan 14, 2026

Author Spotlight: Improving Reproducibility in Vascular Organoids Using ROCK Inhibitors and Microwell Confinement
04:41

Author Spotlight: Improving Reproducibility in Vascular Organoids Using ROCK Inhibitors and Microwell Confinement

Published on: December 13, 2024

2.9K

Angiogenesis induction using organoid-tissue modules: A platform for modular vessel construction.

Jin Ju Park1,2, Eunjeong Seo1,2, HyeRan Gwak1,2

  • 1Department of Dental Regenerative Biotechnology, School of Dentistry, Seoul National University, Republic of Korea.

Journal of Tissue Engineering
|October 22, 2025
PubMed
Summary
This summary is machine-generated.

Researchers developed vascularized organoid tissue modules (Angio-TMs) using endothelial cells. These modules show improved vascularization and potential for regenerative medicine applications.

Keywords:
angiogenesishuman adipose-derived mesenchymal stem cellhuman umbilical vein endothelial cellorganoid-tissue moduletransforming growth factor-beta

More Related Videos

Generation of Human Blood Vessel Organoids from Pluripotent Stem Cells
09:46

Generation of Human Blood Vessel Organoids from Pluripotent Stem Cells

Published on: January 20, 2023

7.9K
Stepwise Cell Seeding on Tessellated Scaffolds to Study Sprouting Blood Vessels
07:49

Stepwise Cell Seeding on Tessellated Scaffolds to Study Sprouting Blood Vessels

Published on: January 14, 2021

3.9K

Related Experiment Videos

Last Updated: Jan 14, 2026

Author Spotlight: Improving Reproducibility in Vascular Organoids Using ROCK Inhibitors and Microwell Confinement
04:41

Author Spotlight: Improving Reproducibility in Vascular Organoids Using ROCK Inhibitors and Microwell Confinement

Published on: December 13, 2024

2.9K
Generation of Human Blood Vessel Organoids from Pluripotent Stem Cells
09:46

Generation of Human Blood Vessel Organoids from Pluripotent Stem Cells

Published on: January 20, 2023

7.9K
Stepwise Cell Seeding on Tessellated Scaffolds to Study Sprouting Blood Vessels
07:49

Stepwise Cell Seeding on Tessellated Scaffolds to Study Sprouting Blood Vessels

Published on: January 14, 2021

3.9K

Area of Science:

  • Tissue Engineering
  • Regenerative Medicine
  • Vascular Biology

Background:

  • Angiogenesis is critical for tissue regeneration but challenging in organoid systems.
  • Functional vasculature is a key limitation in current organoid-based therapies.
  • Developing vascularized constructs is vital for advancing regenerative medicine.

Purpose of the Study:

  • To engineer vascularized organoid tissue modules (Angio-TMs).
  • To assess the vascular functionality and stability of Angio-TMs.
  • To investigate methods for enhancing angiogenic potential in engineered tissues.

Main Methods:

  • Incorporation of human umbilical vein endothelial cells (HUVECs) into scaffold-free organoid constructs.
  • Generation of Angio-TMs with 1% HUVECs for structural stability and reproducibility.
  • In vitro and in vivo assessment of endothelial differentiation and vascular functionality.
  • Inhibition of transforming growth factor (TGF)-β signaling to modulate angiogenic potential.

Main Results:

  • Developed highly reproducible and structurally stable Angio-TMs.
  • Demonstrated clear endothelial differentiation and vascular functionality in vitro and in vivo.
  • Achieved a 2.5-fold increase in vessel length density upon TGF-β signaling inhibition.
  • Confirmed Angio-TMs as a robust platform for vascularized tissue engineering.

Conclusions:

  • Angio-TMs represent a promising modular platform for engineering vascularized tissues.
  • The developed Angio-TMs exhibit significant potential for regenerative medicine and tissue transplantation.
  • Modulating TGF-β signaling offers a strategy to enhance angiogenic capacity in engineered tissues.